Breaking News
Investing Pro 0
💎 Access the Market Tools Trusted by Thousands of Investors Get Started
Close

MGC Pharmaceuticals Ltd (MXC)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
0.003 +0.001    +25.00%
26/09 - Closed. Currency in AUD ( Disclaimer )
  • Volume: 530,552
  • Bid/Ask: 0.002 / 0.003
  • Day's Range: 0.002 - 0.003
Type:  Equity
Market:  Australia
ISIN:  AU000000MXC6 
MGC Pharma 0.003 +0.001 +25.00%

MGC Pharmaceuticals Ltd Company Profile

 
Get an in-depth profile of MGC Pharmaceuticals Ltd, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryPharmaceuticals
SectorHealthcare
Employees

-

Equity Type

ORD

MGC Pharmaceuticals Limited, a bio-pharma company, develops and supplies phytomedicines in worldwide. The company produces and supplies medicinal cannabis products; and non-cannabis phytomedicines. Its principal product candidates include CimetrA, which is in phase III clinical trial for the symptomatic treatment of early COVID-19; CannEpil, a phase IIb cannabis-based therapy for drug-resistant Epilepsy; and CogniCann that is in phase II clinical trial for the symptomatic relief of Dementia. The company also provides ArtemiC range of products and cannabinoid products, as well as non-pharma products. In addition, it offers consulting services, including clinical research services. The company was formerly known as Erin Resources Limited and changed its name to MGC Pharmaceuticals Limited in December 2015. MGC Pharmaceuticals Limited was founded in 2014 and is based in Subiaco, Australia.

Contact Information

Address 295 Rokeby Road Suite 1
Subiaco, 6008
Australia
Phone 61 8 6555 2950
Fax 61 8 6166 0261

Top Executives

Name Age Since Title
Roby Reuven Zomer 43 2016 Co-Founder, CEO, MD & Executive Director
Uri Kramer - 2016 Member of Strategic Advisory Board
Stephen Barry Parker 65 2019 Senior Independent Director & Interim Non-Executive Chair
Wendyl D’Souza - 2018 Member of Medical Advisory Board
Layton Patrick Mills - 2023 Non-Executive Director
Ross Grant Thomas Walker - 2016 Chairman of Strategic Advisory Board & Independent Non-Executive Director
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

MXC Comments

Write your thoughts about MGC Pharmaceuticals Ltd
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Jack Argentum
Jack Argentum Feb 28, 2021 4:30
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Holding $MXC for along time.. now its finally turned the corner with the LSE listing and exposure to European investors, ive watched Roby & Team build this company to where it is today, Def one to watch!!! (Holding💪🤩)
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email